. 2023 Apr 19;48(8):889–894. doi: 10.1093/ced/llad137
© The Author(s) 2023. Published by Oxford University Press on behalf of British Association of Dermatologists.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
Figure 2.
Breakdown of ‘other’ adverse symptoms.